GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » EBITDA Margin %

SQI Diagnostics (FRA:XSQ) EBITDA Margin % : -981.50% (As of Mar. 2023)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. SQI Diagnostics's EBITDA for the three months ended in Mar. 2023 was €-1.70 Mil. SQI Diagnostics's Revenue for the three months ended in Mar. 2023 was €0.17 Mil. Therefore, SQI Diagnostics's EBITDA margin for the quarter that ended in Mar. 2023 was -981.50%.


SQI Diagnostics EBITDA Margin % Historical Data

The historical data trend for SQI Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics EBITDA Margin % Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -479.16 -362.99 -693.75 -1,012.85 -149.55

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.30 -228.34 -368.35 -701.64 -981.50

Competitive Comparison of SQI Diagnostics's EBITDA Margin %

For the Diagnostics & Research subindustry, SQI Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's EBITDA Margin % falls into.



SQI Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

SQI Diagnostics's EBITDA Margin % for the fiscal year that ended in Sep. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2022 )/Revenue (A: Sep. 2022 )
=-9.175/6.135
=-149.55 %

SQI Diagnostics's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-1.698/0.173
=-981.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SQI Diagnostics  (FRA:XSQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


SQI Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines